BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12450322)

  • 21. Involvement of bone morphogenetic protein-6 in differential regulation of aldosterone production by angiotensin II and potassium in human adrenocortical cells.
    Inagaki K; Otsuka F; Suzuki J; Kano Y; Takeda M; Miyoshi T; Otani H; Mimura Y; Ogura T; Makino H
    Endocrinology; 2006 Jun; 147(6):2681-9. PubMed ID: 16527843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.
    Hayashida W; Kihara Y; Yasaka A; Inagaki K; Iwanaga Y; Sasayama S
    J Mol Cell Cardiol; 2001 Apr; 33(4):733-44. PubMed ID: 11273726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla.
    Chan SH; Hsu KS; Huang CC; Wang LL; Ou CC; Chan JY
    Circ Res; 2005 Oct; 97(8):772-80. PubMed ID: 16151022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cells.
    Szekeres M; Turu G; Orient A; Szalai B; Süpeki K; Cserzo M; Várnai P; Hunyady L
    Mol Cell Endocrinol; 2009 Apr; 302(2):244-53. PubMed ID: 19418629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B.
    Ramanjaneya M; Conner AC; Chen J; Kumar P; Brown JE; Jöhren O; Lehnert H; Stanfield PR; Randeva HS
    J Endocrinol; 2009 Aug; 202(2):249-61. PubMed ID: 19460850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells.
    Zimpelmann J; Burns KD
    Am J Physiol Renal Physiol; 2009 Feb; 296(2):F337-46. PubMed ID: 19052102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells.
    Alexander LD; Cui XL; Falck JR; Douglas JG
    Kidney Int; 2001 Jun; 59(6):2039-53. PubMed ID: 11380805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
    Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
    Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the lipoxygenase pathway in angiotensin II-induced vasoconstriction in the human placenta.
    Kisch ES; Jaffe A; Knoll E; Stern N
    Hypertension; 1997 Mar; 29(3):796-801. PubMed ID: 9052898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions.
    Natarajan R; Scott S; Bai W; Yerneni KK; Nadler J
    Hypertension; 1999 Jan; 33(1 Pt 2):378-84. PubMed ID: 9931133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.
    Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
    Su Z; Zimpelmann J; Burns KD
    Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 20-Hydroxyeicosatetraenoic acid mediates angiotensin ii-induced phospholipase d activation in vascular smooth muscle cells.
    Parmentier JH; Muthalif MM; Nishimoto AT; Malik KU
    Hypertension; 2001 Feb; 37(2 Pt 2):623-9. PubMed ID: 11230346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Angiotensin II-induced podocyte apoptosis: role of the MAPK subtypes].
    Lai XX; Ding GH; Huang CX; Shi M; Chen C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):131-4. PubMed ID: 15100728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes.
    Werz O; Bürkert E; Samuelsson B; Rådmark O; Steinhilber D
    Blood; 2002 Feb; 99(3):1044-52. PubMed ID: 11807011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II-sensitization in human adrenocortical cells.
    Krug AW; Vleugels K; Schinner S; Lamounier-Zepter V; Ziegler CG; Bornstein SR; Ehrhart-Bornstein M
    Int J Obes (Lond); 2007 Oct; 31(10):1605-16. PubMed ID: 17452987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that 12-lipoxygenase product 12-hydroxyeicosatetraenoic acid activates p21-activated kinase.
    Wen Y; Gu J; Knaus UG; Thomas L; Gonzales N; Nadler JL
    Biochem J; 2000 Jul; 349(Pt 2):481-7. PubMed ID: 10880347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells.
    Romero DG; Plonczynski MW; Gomez-Sanchez EP; Yanes LL; Gomez-Sanchez CE
    Endocrinology; 2006 Aug; 147(8):3889-97. PubMed ID: 16627589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-derived growth factor is a potent inhibitor of angiotensin II-induced aldosterone synthesis.
    Natarajan R; Nadler J
    Mol Cell Endocrinol; 1992 Jan; 83(1):57-63. PubMed ID: 1312960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.